Pradžia › Pneumonija › Utah
Pneumonija klinikiniai tyrimai Utah
7 tyrimai dėl Pneumonija ieško dalyvių vietose Utah.
Miestai Utah
Oficialus tyrimo tekstas (anglų kalba)
A Study of COVID-19 Vaccine(s) in Children and Adults
- J. Lewis Research, Inc. / Foothill Family Clinic, Salt Lake City
- J. Lewis Research, Inc. / Foothill Family Clinic South, Salt Lake City
Renkami dalyviai3 fazėLaukiami sveiki savanoriai
Amžius 5 ir vyresni · Visoms lytims · Atnaujinta 2026-09-28 · NCT07798648A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
- Alpine Research Organization, Clinton
Renkami dalyviai3 fazė
Amžius 12 ir vyresni · Visoms lytims · Atnaujinta 2026-09-25 · NCT06679140A Study to Learn About a COVID-19 Vaccine in Healthy Adults 18 Through 64 Years of Age
- J. Lewis Research, Inc. / Foothill Family Clinic, Salt Lake City
Renkami dalyviai4 fazėLaukiami sveiki savanoriai
Amžius nuo 18 iki 64 · Visoms lytims · Atnaujinta 2026-08-07 · NCT07730450The APS Phenotyping Study
- Intermountain Medical Center, Murray
- University of Utah, Salt Lake City
Renkami dalyviaiStebimasis tyrimas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-02-20 · NCT06521502Comparing Antibiotic Treatment Strategies for Children With Pneumonia in Outpatient Settings: (STAMPP)
- Primary Children's Hospital, Salt Lake City
Renkami dalyviai
12 Months – 71 Months · Visoms lytims · Atnaujinta 2026-01-27 · NCT06986148Follow-up Automatically vs. As-Needed Comparison (FAAN-C) Trial
- Intermountain Primary Children's Hospital Larry H. and Gail Miller Family Campus, Lehi
- Primary Children's Hospital, Salt Lake City
Renkami dalyviai
Iki 18 metų · Visoms lytims · Atnaujinta 2025-12-10 · NCT05471908Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
- aTyr Investigative Site, Salt Lake City
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2025-05-07 · NCT05892614Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.